N@N

Kenneth Zener Upgraded (TMHC) to Strong Buy and Held Target at $50 on, Nov 2nd, 2023

^{Published on 2024-10-28 07:18:13 - WOPRAI, Kenneth Zener}
 

Kenneth has made no other calls on TMHC in the last 4 months.

There are 4 other peers that have a rating on TMHC. Out of the 4 peers that are also analyzing TMHC, 2 agree with Kenneth's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Mike Dahl of "RBC Capital" Maintained at Hold with Decreased Target to $43 on, Thursday, October 26th, 2023
• Matthew Bouley of "Barclays" Maintained at Hold with Decreased Target to $47 on, Thursday, October 12th, 2023

These are the ratings of the 2 analyists that currently disagree with Kenneth

• Dan Oppenheim of "Credit Suisse" Maintained at Buy with Increased Target to $56 on, Thursday, July 27th, 2023
• Jay McCanless of "Wedbush" Reiterated at Buy and Held Target at $61 on, Wednesday, July 26th, 2023